The role of JAK2V617F-positive endothelial cells in aberrant haemostasis and thrombosis
Patients with MPNs commonly experience complications caused by dysfunctional haemostasis and thrombosis. Patient treatment is limited and aimed at preventing these adverse events, typically by low-dose aspirin therapy. However, a subset of patients experience increased risk of bleeding diatheses and...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of York
2016
|
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701476 |